442-Q CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation

• Torsten Tonn,
• Winfried Wels,
• Hans Klingemann,
• Jiri Eitler,
• Natalie Wotschel,
• Laurent Boissel,
• Paola Ortiz Montero,
• Wiebke Rackwitz,
• Venugopal Gudipati,
• Johannes Huppa

Affiliations

Torsten Tonn

2German Red Cross Blood Donation Service North-East, Dresden, Saxony, Germany

Winfried Wels

6Frankfurt Cancer Institute, Goethe University, Frankfurt am Main, Hesse, Germany

Hans Klingemann

5ImmunityBio Inc, Culver City, CA, USA

Jiri Eitler

1Faculty of Medicine Carl Gustav Carus, Dresden, Germany

Natalie Wotschel

3Faculty of Medicine Carl Gustav Carus, Dresden University of Technology, Dresden, Saxony, Germany

Laurent Boissel

5ImmunityBio Inc, Culver City, CA, USA

Paola Ortiz Montero

3Faculty of Medicine Carl Gustav Carus, Dresden University of Technology, Dresden, Saxony, Germany

Wiebke Rackwitz

2German Red Cross Blood Donation Service North-East, Dresden, Saxony, Germany

Venugopal Gudipati

4Institute for Hygiene and Applied Immunology, Medical University of Vienna, Vienna, Austria, Austria

Johannes Huppa

4Institute for Hygiene and Applied Immunology, Medical University of Vienna, Vienna, Austria, Austria